Setting

Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

Published: 30 Apr 2023 | Report Code: 10248388 | Pages: 258

Global Active Pharmaceutical Ingredients (API) Market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 141 tables and 111 figures, this 258-page report “Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Global Active Pharmaceutical Ingredients (API) Market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include the identification and investigation of the following aspects:
•  Market Structure 
•  Growth Drivers 
•  Restraints and Challenges
•  Emerging Product Trends & Market Opportunities
•  Porter’s Five Forces

 

The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Global Active Pharmaceutical Ingredients (API) Market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

 

Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Small Molecule APIs
•  Large Molecule APIs

 

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Synthetic API
    o  Branded Synthetic API
    o  Generic Synthetic API
•  Biotech API
    o  By type 
         o  Monoclonal Antibodies
         o  Recombinant Proteins
         o  Vaccines
         o  Other Biotech APIs
    o  By Category 
         o  Innovative Biologic API
         o  Generic Biosimilar API
    o  By Expression 
         o  Mammalian Expression
         o  Microbial Expression
         o  Yeast Expression
         o  Insect Expression
         o  Other Expression Technologies
•  HPAPI
    o  Branded HPAPI
    o  Generic HPAPI

 

Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Captive Manufacturing
    o  Branded Captive API
    o  Generic Captive API
•  Merchant Manufacturing
    o  By Drug Type 
        o  Branded Merchant API
        o  Generic Merchant API
    o  By Drug Synthesis 
        o  Merchant Synthetic API
        o  Merchant Biotech API

 

By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Infectious Diseases
•  Oncology
•  Ophthalmology 
•  Cardiovascular Disorders
•  Central Nervous System
•  Pulmonary Disorders
•  Orthopedics
•  Other Applications

 

By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Branded Prescription Drugs
•  Generic Prescription Drugs
•  OTC Drugs

 

Geographically, the following regions together with the listed national/local markets are fully investigated:
•  North America (U.S., Canada, and Mexico)
•  Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•  APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•  South America (Brazil, Chile, Argentina, Rest of South America)
•  MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)

 

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players: 

AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific

 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:

1 Introduction    13
1.1 Industry Definition and Research Scope    13
1.1.1 Industry Definition    13
1.1.2 Research Scope    14
1.2 Research Methodology    17
1.2.1 Overview of Market Research Methodology    17
1.2.2 Market Assumption    18
1.2.3 Secondary Data    18
1.2.4 Primary Data    18
1.2.5 Data Filtration and Model Design    19
1.2.6 Market Size/Share Estimation    20
1.2.7 Research Limitations    21
1.3 Executive Summary    22
2 Market Overview and Dynamics    25
2.1 Market Size and Forecast    25
2.1.1 Impact of COVID-19 on World Economy    26
2.1.2 Impact of COVID-19 on the Market    29
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery    36
2.2 Major Growth Drivers    40
2.3 Market Restraints and Challenges    48
2.4 Emerging Opportunities and Market Trends    51
2.5 Porter’s Fiver Forces Analysis    55
3 Segmentation of Global Market by Molecule    59
3.1 Market Overview by Molecule    59
3.2 Small Molecule APIs    61
3.3 Large Molecule APIs    62
4 Segmentation of Global Market by Synthesis    63
4.1 Market Overview by Synthesis    63
4.2 Synthetic API    65
4.2.1 Branded Synthetic API    66
4.2.2 Generic Synthetic API    67
4.3 Biotech API    68
4.3.1 Biotech API by Drug Type    69
4.3.1.1 Monoclonal Antibodies    70
4.3.1.2 Recombinant Proteins    71
4.3.1.3 Vaccines    72
4.3.1.4 Other Biotech APIs    73
4.3.2 Biotech API by Category    74
4.3.2.1 Innovative Biologic API    75
4.3.2.2 Generic Biosimilar API    76
4.3.3 Biotech API by Expression Technology    77
4.3.3.1 Mammalian Expression    78
4.3.3.2 Microbial Expression    79
4.3.3.3 Yeast Expression    80
4.3.3.4 Insect Expression    81
4.3.3.5 Other Expression Technologies    82
4.4 HPAPI    83
4.4.1 Branded HPAPI    84
4.4.2 Generic HPAPI    85
5 Segmentation of Global Market by Manufacturing Process    86
5.1 Market Overview by Manufacturing Process    86
5.2 Captive Manufacturing    88
5.2.1 Branded Captive API    89
5.2.2 Generic Captive API    90
5.3 Merchant Manufacturing    91
5.3.1 Merchant Manufacturing by Drug Type    92
5.3.1.1 Branded Merchant API    93
5.3.1.2 Generic Merchant API    94
5.3.2 Merchant Manufacturing by Drug Synthesis    95
5.3.2.1 Merchant Synthetic API    96
5.3.2.2 Merchant Biotech API    97
6 Segmentation of Global Market by Therapeutic Application    98
6.1 Market Overview by Therapeutic Application    98
6.2 Infectious Diseases    100
6.3 Oncology    101
6.4 Ophthalmology    102
6.5 Cardiovascular Disorders    103
6.6 Central Nervous System    104
6.7 Pulmonary Disorders    105
6.8 Orthopedics    106
6.9 Other Applications    107
7 Segmentation of Global Market by Drug Type    108
7.1 Market Overview by Drug Type    108
7.2 Branded Prescription Drugs    110
7.3 Generic Prescription Drugs    111
7.4 OTC Drugs    112
8 Segmentation of Global Market by Region    113
8.1 Geographic Market Overview 2022-2032    113
8.2 North America Market 2022-2032 by Country    117
8.2.1 Overview of North America Market    117
8.2.2 U.S.    120
8.2.3 Canada    130
8.2.4 Mexico    132
8.3 European Market 2022-2032 by Country    134
8.3.1 Overview of European Market    134
8.3.2 UK    137
8.3.3 France    139
8.3.4 Germany    141
8.3.5 Spain    143
8.3.6 Italy    145
8.3.7 Russia    147
8.3.8 Rest of European Market    149
8.4 Asia-Pacific Market 2022-2032 by Country    151
8.4.1 Overview of Asia-Pacific Market    151
8.4.2 China    154
8.4.3 Japan    156
8.4.4 India    159
8.4.5 Australia    161
8.4.6 South Korea    163
8.4.7 Rest of APAC Region    165
8.5 South America Market 2022-2032 by Country    167
8.5.1 Argentina    170
8.5.2 Brazil    172
8.5.3 Chile    174
8.5.4 Rest of South America Market    176
8.6 MEA Market 2022-2032 by Country    177
8.6.1 UAE    180
8.6.2 Saudi Arabia    182
8.6.3 South Africa    184
8.6.4 Other National Markets    186
9 Competitive Landscape    187
9.1 Overview of Key Vendors    187
9.2 New Product Launch, Partnership, Investment, and M&A    190
9.3 Company Profiles    191
AbbVie Inc.    191
Astrazeneca    193
Aurobindo Pharma Ltd.    198
BASF    201
Bayer AG    204
Boehringer Ingelheim    208
Catalent Inc.    213
Dr. Reddy's Laboratories    216
F. Hoffmann-La Roche    218
GlaxoSmithKline plc    221
Lonza Group    226
Lupin Limited    230
Merck & Co., Inc.    233
Mylan NV    236
Novartis International AG    239
Pfizer Inc.    242
Sanofi    247
Sun Pharmaceutical Industries Ltd.    250
Teva Pharmaceutical Industries Ltd.    253
Thermo Fisher Scientific    255
Related Reports and Products    258

 

List of Tables:

Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032    23
Table 2. World Economic Outlook, 2021-2031    27
Table 3. World Economic Outlook, 2021-2023    28
Table 4. Scenarios for Economic Impact of Ukraine Crisis    37
Table 5. World Health Spending by Region, $ bn, 2013-2020    46
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn    47
Table 7. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market    51
Table 8. Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn    59
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    63
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn    65
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn    69
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn    74
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn    77
Table 14. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn    83
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    86
Table 16. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn    88
Table 17. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn    92
Table 18. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn    95
Table 19. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    98
Table 20. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn    108
Table 21. Global Active Pharmaceutical Ingredients (API) Market by Region, 2022-2032, $ bn    114
Table 22. Leading National Active Pharmaceutical Ingredients (API) Market, 2022 and 2032, $ bn    116
Table 23. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    119
Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    122
Table 25. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    122
Table 26. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    122
Table 27. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, ?sed on Dollar Value    124
Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    131
Table 29. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    131
Table 30. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    131
Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    133
Table 32. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    133
Table 33. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    133
Table 34. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    136
Table 35. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    138
Table 36. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    138
Table 37. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    138
Table 38. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    140
Table 39. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    140
Table 40. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    140
Table 41. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    142
Table 42. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    142
Table 43. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    142
Table 44. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    144
Table 45. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    144
Table 46. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    144
Table 47. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    146
Table 48. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    146
Table 49. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    146
Table 50. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    148
Table 51. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    148
Table 52. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    148
Table 53. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn    150
Table 54. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    153
Table 55. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    155
Table 56. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    155
Table 57. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    155
Table 58. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    158
Table 59. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    158
Table 60. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    158
Table 61. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    160
Table 62. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    160
Table 63. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    160
Table 64. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    162
Table 65. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    162
Table 66. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    162
Table 67. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    164
Table 68. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    164
Table 69. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    164
Table 70. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn    166
Table 71. South America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    169
Table 72. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    171
Table 73. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    171
Table 74. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    171
Table 75. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    173
Table 76. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    173
Table 77. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    173
Table 78. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    175
Table 79. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    175
Table 80. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    175
Table 81. MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    179
Table 82. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    181
Table 83. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    181
Table 84. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    181
Table 85. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    183
Table 86. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    183
Table 87. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    183
Table 88. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    185
Table 89. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    185
Table 90. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    185
Table 91. AbbVie Inc.: Company Snapshot    191
Table 92. AbbVie Inc.: Business Segmentation    192
Table 93. AbbVie Inc.: Product Portfolio    192
Table 94. Astrazeneca: Company Snapshot    193
Table 95. Aurobindo Pharma Ltd.: Company Snapshot    198
Table 96. Aurobindo Pharma Ltd.: Product Portfolio    199
Table 97. BASF: Company Snapshot    201
Table 98. BASF: Business Segmentation    202
Table 99. Bayer AG: Company Snapshot    204
Table 100. Bayer AG: Business Segmentation    205
Table 101. Bayer AG: Product Portfolio    205
Table 102. Boehringer Ingelheim: Company Snapshot    208
Table 103. Boehringer Ingelheim: Product Portfolio    209
Table 104. Catalent Inc.: Company Snapshot    213
Table 105. Catalent Inc.: Business Segmentation    214
Table 106. Catalent Inc.: Product Portfolio    214
Table 107. Dr. Reddy's Laboratories: Company Snapshot    216
Table 108. Dr. Reddy's Laboratories: Business Segmentation    216
Table 109. F. Hoffmann-La Roche: Company Snapshot    218
Table 110. F. Hoffmann-La Roche: Clinical Trial Service    218
Table 111. F. Hoffmann-La Roche: Business Segmentation    219
Table 112. F. Hoffmann-La Roche: Revenue by Region    219
Table 113. GlaxoSmithKline: Company Snapshot    221
Table 114. GlaxoSmithKline: Business Segmentation    222
Table 115. GlaxoSmithKline: Product Portfolio    223
Table 116. Lonza Group: Company Snapshot    226
Table 117. Lonza Group: Business Segmentation    227
Table 118. Lonza Group: Product Portfolio    227
Table 119. Lupin Limited: Company Snapshot    230
Table 120. Lupin Limited: Business Segmentation    231
Table 121. Merck & Co., Inc.: Company Snapshot    233
Table 122. Merck & Co., Inc.: Business Segmentation    234
Table 123. Mylan NV: Company Snapshot    236
Table 124. Mylan NV: Breakdown of Revenue by Region, 2022    237
Table 125. Mylan NV: Breakdown of Revenue by Product Category, 2022    237
Table 126. Novartis International AG: Company Snapshot    239
Table 127. Novartis International AG: Business Segmentation    240
Table 128. Pfizer Inc.: Company Snapshot    242
Table 129. Pfizer Inc.: Business Segmentation    243
Table 130. Pfizer Inc.: Breakdown of Revenue by Product Category    243
Table 131. Pfizer Inc.: Breakdown of Revenue by Region    244
Table 132. Pfizer Inc.: Product Portfolio    244
Table 133. Sanofi: Company Snapshot    247
Table 134. Sanofi: Business Segmentation    248
Table 135. Sanofi: Breakdown of Revenue by Region    248
Table 136. Sun Pharmaceutical Industries Limited: Company Snapshot    250
Table 137. Teva Pharmaceutical Industries Ltd.: Company Snapshot    253
Table 138. Teva Pharmaceutical Industries Ltd.: Business Segmentation    254
Table 139. Thermo Fisher Scientific: Company Snapshot    255
Table 140. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, %6
Table 141. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, %6

 

List of Figures:

Figure 1. Research Method Flow Chart    17
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    20
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032    22
Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    25
Figure 5. Impact of COVID-19 on Business    29
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market    40
Figure 7. GDP per capita in the World, 1960-2022, $ thousand    43
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million    44
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    45
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060    45
Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market    48
Figure 12. Investment Opportunity Analysis    52
Figure 13. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market    55
Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue    60
Figure 15. Global Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%)    60
Figure 16. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn    61
Figure 17. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn    62
Figure 18. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue    63
Figure 19. Contribution to Global 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)    64
Figure 20. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn    65
Figure 21. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn    66
Figure 22. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn    67
Figure 23. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn    68
Figure 24. Global Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn    70
Figure 25. Global Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn    71
Figure 26. Global Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn    72
Figure 27. Global Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn    73
Figure 28. Global Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn    75
Figure 29. Global Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn    76
Figure 30. Global Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn    78
Figure 31. Global Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn    79
Figure 32. Global Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn    80
Figure 33. Global Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn    81
Figure 34. Global Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn    82
Figure 35. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn    83
Figure 36. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn    84
Figure 37. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn    85
Figure 38. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue    86
Figure 39. Contribution to Global 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)    87
Figure 40. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn    88
Figure 41. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn    89
Figure 42. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn    90
Figure 43. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn    91
Figure 44. Global API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn    93
Figure 45. Global API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn    94
Figure 46. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn    96
Figure 47. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn    97
Figure 48. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue    98
Figure 49. Contribution to Global 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)    99
Figure 50. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn    100
Figure 51. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn    101
Figure 52. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn    102
Figure 53. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn    103
Figure 54. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn    104
Figure 55. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn    105
Figure 56. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn    106
Figure 57. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn    107
Figure 58. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue    108
Figure 59. Contribution to Global 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)    109
Figure 60. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn    110
Figure 61. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn    111
Figure 62. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn    112
Figure 63. Global Market Snapshot by Region    113
Figure 64. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2022-2032, % of Revenue    114
Figure 65. Contribution to Global 2023-2032 Cumulative Revenue by Region, Value ($ bn) and Share (%)    115
Figure 66. North American Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    118
Figure 67. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    118
Figure 68. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    119
Figure 69. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    121
Figure 70. Manufacturing Sites of APIs for U.S. Market by Country or Region,    126
Figure 71. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List    126
Figure 72. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List    127
Figure 73. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    130
Figure 74. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn    132
Figure 75. European Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    135
Figure 76. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    135
Figure 77. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    136
Figure 78. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn    137
Figure 79. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn    139
Figure 80. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn    141
Figure 81. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn    143
Figure 82. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn    145
Figure 83. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn    147
Figure 84. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn    149
Figure 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    152
Figure 86. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    152
Figure 87. Contribution to APAC 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    153
Figure 88. Active Pharmaceutical Ingredients (API) Market in China, 2022-2032, $ bn    154
Figure 89. Active Pharmaceutical Ingredients (API) Market in Japan, 2022-2032, $ bn    157
Figure 90. Active Pharmaceutical Ingredients (API) Market in India, 2022-2032, $ bn    159
Figure 91. Active Pharmaceutical Ingredients (API) Market in Australia, 2022-2032, $ bn    161
Figure 92. Active Pharmaceutical Ingredients (API) Market in South Korea, 2022-2032, $ bn    163
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2022-2032, $ bn    165
Figure 94. South America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    168
Figure 95. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    168
Figure 96. Contribution to South America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    169
Figure 97. Active Pharmaceutical Ingredients (API) Market in Argentina, 2022-2032, $ bn    170
Figure 98. Active Pharmaceutical Ingredients (API) Market in Brazil, 2022-2032, $ bn    172
Figure 99. Active Pharmaceutical Ingredients (API) Market in Chile, 2022-2032, $ bn    174
Figure 100. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2022-2032, $ bn    176
Figure 101. Active Pharmaceutical Ingredients (API) Market in MEA, 2022-2032, $ bn    178
Figure 102. Breakdown of MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    178
Figure 103. Contribution to MEA 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    179
Figure 104. Active Pharmaceutical Ingredients (API) Market in UAE, 2022-2032, $ bn    180
Figure 105. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2022-2032, $ bn    182
Figure 106. Active Pharmaceutical Ingredients (API) Market in South Africa, 2022-2032, $ bn    184
Figure 107. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period    187
Figure 108. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022    194
Figure 109. AstraZeneca: Breakdown of Revenue by Region, 2022    194
Figure 110. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022    209
Figure 111. Boehringer Ingelheim: R&D Investement, 2019-2022    210
Selected Key Players: 

AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)